ScienceDex / Researcher record
Toshihiro Shioda
- Massachusetts General Hospital · Genetics (topic-inferred)
- Massachusetts General Hospital · Urology (topic-inferred)
- Massachusetts General Hospital · Pharmacology (topic-inferred)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,956,230 | 6 | #5,583 |
| 2025 | $1,505,135 | 4 | #10,001 |
| 2026 | $1,430,791 | 3 | #14,353 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected6 records
- FY20254 records
- FY20263 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 3124209Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Anatomy & Cell Biology
FY2024 award records by amount
NIH award records listing Toshihiro Shioda as a PI. Multi-PI records show the full award amount for context.
- 5R01ES023316-12R01Co-investigatorChromatin contacts are germline-transmissable vehicles underlying epigenetic transgenerational inheritanceUniversity of California-Irvine · Anatomy & Cell Biology (NIH department code)$640.1Kaward amount
- 1R01ES035401-01A1R01Contact PIEnvironmental chemicals impair epigenetic suppression of the endogenous retrovirus HML-2 in human primordial germ cells, predisposing the next generation to malignancies through HML-2 reactivationMassachusetts General Hospital · Genetics (topic-inferred)$620.9Kaward amount
- 1R21DA059789-01R21Contact PICannabinoids as an environmental risk factor of testicular cancer: Assessment using cell culture models of human and mouse primordial germ cells and by exposure of pregnant miceMassachusetts General Hospital · Urology (topic-inferred)$264.8Kaward amount
- 5R21ES034468-02R21Contact PIApplications of the long-term culture human primordial germ cell-like cells to toxicological assessments and mechanistic studies on chemically caused heritable human health threatsMassachusetts General Hospital · Pharmacology (topic-inferred)$208.8Kaward amount
- 5R21HD110839-02R21Contact PIRoles of the LTR5_Hs human-specific endogenous retroviruses in primordial germ cellsMassachusetts General Hospital · Genetics (topic-inferred)$208.8Kaward amount
- 3R01ES031139-04S1R01Co-investigatorInteractions between prenatal obesogen exposure and Total Western diet lead to a transgenerational thrifty phenotype: functional and epigenomic analysis of effects in fat and liverUniversity of California-Irvine · Anatomy & Cell Biology (NIH department code)$13Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Toshihiro Shioda as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5583
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Toshihiro Shioda.